Get started
Author

Andres E. Daryanani

Observed names: A Daryanani, A Daryanani Acevedo, A E Daryanani, A E Daryanani Acevedo, Andres Daryanani, Andres Daryanani Acevedo, Andres E Daryanani, Andrés Daryanani, Daryanani, Andres
ORCID: 0009-0007-8425-4225
Observed ORCID: 0009-0007-8425-4225
OpenAlex ID: A5087883371
Cardiotoxicities of Novel Therapies in Hematologic Malignancies: Chimeric Antigen Receptor T-Cell Therapy and Bispecific T-Cell Engager Therapy
2023 · Rosalyn I. Marar, Muhannad Aboud Abbasi, et al. · JCO Oncology Practice · 17
Ensuring Medical Device Safety: The Role of Standards Organizations and Regulatory Bodies
2025 · Andres E. Daryanani, Ugwuji N. Maduekwe, et al. · Journal of Medical Systems · 15
Baseline echocardiographic variables as predictors of hemodynamically significant cytokine release syndrome in adults treated with CD19 CAR T-cell therapy for hematological malignancies
2024 · Andres E. Daryanani, Muhannad A. Abbasi, et al. · Cardio-Oncology · 4
PDF
Cardiotoxicities of Novel Therapies in Hematological Malignancies: Monoclonal Antibodies and Enzyme Inhibitors
2023 · Sruti Prathivadhi-Bhayankaram, Muhannad Aboud Abbasi, et al. · Current Problems in Cardiology · 2
Can Dobutamine Stress Echocardiography (dse) Be Used to Predict Cardiovascular Outcomes 20 Years After Chest Radiotherapy?
2024 · Diana B. Collantes-Hoyos, Rafael Toro-Manotas, et al. · Journal of the American College of Cardiology · 1
Off the Books: A Scoping Review of the Minority Tax and Professional Advancement in Academic Surgery
2026 · Alexandra C. Istl, Andrés Daryanani, et al. · Journal of Surgical Research
Assessing double product derived from stress echocardiography as a prognostic indicator of major adverse cardiac events in patients with breast cancer treated with radiotherapy
2025 · Juan Manuel Garzon-Dangond, Maria F. Gomez Ardila, et al. · Cardio-Oncology
PDF
AI in medicine: Hype, hope, and the path forward
2025 · A E Daryanani, J M Ehrenfeld · South African Medical Journal
PDF
Abstract 4141352: Can quantifiable aortic or coronary artery calcifications in the standard of care baseline CT or PET-CT scan of patients with Hodgkin or non-Hodgkin lymphoma serve as a predictor of Major Adverse Cardiovascular Events?
2024 · MARIA F. GOMEZ ARDILA, Andres Daryanani, et al. · Circulation
Is there an association of anthracyclines with HFrEF and/or HFpEF in patients treated for breast cancer or lymphoma after 30 years of follow-up? Insights from the Rochester epidemiology project
2024 · E Tellez Garcia, C M Larsen, et al. · European Heart Journal
Can the presence of aortic or coronary artery calcifications in the standard of care baseline CT or PET-CT scan of patients with Hodgkin or non-Hodgkin lymphoma be used as a predictor of MACE?
2024 · M Gomez Ardila, A Daryanani, et al. · European Heart Journal
PDF
Double product derived from exercise stress echocardiography (ESE) or dobutamine stress echocardiography (DSE) in patients with a history of breast cancer and radiotherapy (RXT) exposure and MACE
2024 · J Garzon-Dangond, M F Gomez-Ardila, et al. · European Heart Journal
Are There Any Sex-based Disparities in the Development of Heart Failure or Cardiotoxicity in Lymphoma Patients Treated With Anthracyclines?
2024 · Nikki Neequaye, Carolina Ricaurte-Carmona, et al. · Journal of the American College of Cardiology
Association of Anthracyclines With Major Adverse Cardiovascular Events (mace) in Patients Treated for Breast Cancer or Lymphoma After 30 Years of Follow up
2024 · Eduardo Tellez Garcia, Diana B. Collantes-Hoyos, et al. · Journal of the American College of Cardiology
Major Adverse Cardiovascular Events (mace) in Patients With B-cell Lymphoma After Cd19 Car T-cell Therapy After Nine Months of Follow-up: a Retrospective Cohort Study
2024 · Enrique J. Alvirez Gonzalez, Andres E. Daryanani, et al. · Journal of the American College of Cardiology
Abstract 18300: Do Current Cardiovascular Risk Models Predict the Development of Cardiotoxicity in Lymphoma Patients Treated With Anthracycline?
2023 · Carolina Ricaurte, Sebastian Santos Patarroyo, et al. · Circulation
Abstract 17612: Are There Changes in Cardiac Valve Morphology or Valve Disease Progression After CD19 CAR T-cell Therapy-Induced Cytokine Release Syndrome? An Echocardiographic Study
2023 · Andres E Daryanani, Sebastian Santos Patarroyo, et al. · Circulation
Abstract 18312: Is the Presence of Multiple Valvular Heart Disease or Mitral Annular Calcification in Cancer Patients Exposed to Chest Radiotherapy or Chemotherapy That Underwent Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis Associated With MACE?
2023 · Sebastian Santos Patarroyo, Carolina Ricaurte, et al. · Circulation
Is staging for cardiac damage in aortic stenosis associated with MACE in cancer patients with prior radiotherapy or chemotherapy that underwent transcatheter aortic valve replacement?
2023 · S Santos Patarroyo, R E Toro Manotas, et al. · European Heart Journal
PDF
Is dobutamine stress echocardiography a good screening tool for coronary artery disease in breast cancer patients that underwent treatment with radiotherapy?
2023 · D B Collantes Hoyos, R E Toro Manotas, et al. · European Heart Journal
PDF
Even the presence of minimal changes in regional wall motion abnormalities with exercise stress echocardiography predicts MACE and all-cause mortality in patients with previous chest radiotherapy
2023 · R Toro Manotas, S Santos Patarroyo, et al. · European Heart Journal
PDF
Diastolic Function Assessment in Non-hodgkin Lymphoma Patients by Different Cumulative Doses of Anthracyclines
2023 · Bryan Alexis Vallejo, Juan Andres Quintero-Martinez, et al. · Journal of the American College of Cardiology
Influence of Chest Radiotherapy on Diastolic Function Assessment During Stress Echocardiography in Cancer Patients and Its Relationship With Exercise Capacity and Mortality After 5 Years of Treatment Completion
2023 · Rafael Toro-Manotas, Crystal Gomez Estrada, et al. · Journal of the American College of Cardiology
Is Systolic and Diastolic Function Including Global Longitudinal Strain by Echocardiography Compromised in Adult Patients Treated With Cd19 Car T-cell Therapies for Hematological Malignancies in Those That Developed Cytokine Release Syndrome?
2023 · Andres Daryanani, Bryan Alexis Vallejo, et al. · Journal of the American College of Cardiology
Echocardiographic Predictors of 18-month All-cause Mortality in Cancer Patients (chest Radiotherapy and Chemotherapy Vs Chemotherapy Only Vs Controls) That Underwent Tavr for Severe Aortic Stenosis
2023 · Sebastian Santos-Patarroyo, Bryan Alexis Vallejo, et al. · Journal of the American College of Cardiology
PDF
Works count: 27
Citation count: 39
H-index: 3
I10-index: 2
Year
Topic
Type